Suzhou Maxwell Technologies (300751.SZ) plans to participate in the establishment of Suzhou Xinwei Second-Phase Entrepreneurial Investment Partnership Enterprise.

17:36 10/02/2026

Maiwei Co., Ltd. (300751.SZ) announced that, in accordance with the company's strategic planning needs, in order to further expand the company's business scope, better utilize the professional expertise and resource advantages of professional institutions, integrate resources from all parties, and enhance the company's overall competitiveness. The company has partnered with professional investment institution Suzhou Xinrui Entrepreneurship Investment Partnership Enterprise (Limited Partnership) (hereinafter referred to as "Xinrui Venture", "General Partner", "Fund Manager"). The company intends to subscribe for fund shares in Suzhou Xin Wei Second Phase Entrepreneurship Investment Partnership Enterprise (Limited Partnership) as a limited partner with its own funds to make a capital contribution of 90 million yuan.

Suzhou Maxwell Technologies (300751.SZ) has announced that, in accordance with the strategic needs of the company's planning, in order to further expand the company's business scope and better utilize the professional strength and resource advantages of professional institutions, integrate various resources, and enhance the company's overall competitiveness. The company has cooperated with the professional investment institution Suzhou Xinrui Venture Capital Partnership Enterprise (Limited Partnership) (hereinafter referred to as "Xinrui Venture Capital", "General Partner", "Fund Manager"). The company plans to act as a limited partner to subscribe for 90 million yuan in capital with its own funds, to participate in the subscription for the fund shares of Suzhou Xin Second Phase Venture Capital Partnership Enterprise (Limited Partnership).

HX COLDCHAIN (01641) subscribes to 50 million RMB worth of financial products.

CF PHARMTECH (02652) spent approximately HK$370,500 to repurchase 10,500 shares on February 10th.

DONGYUE GROUP (00189) announces profit growth, expects the company's owner's profit to increase by over 100% compared to the previous year in 2025.

HX COLDCHAIN (01641) subscribes to 50 million RMB worth of financial products.

CF PHARMTECH (02652) spent approximately HK$370,500 to repurchase 10,500 shares on February 10th.

DONGYUE GROUP (00189) announces profit growth, expects the company's owner's profit to increase by over 100% compared to the previous year in 2025.